Cancer Research Technology Limited (CRT) is a leading player in the biotechnology sector, headquartered in Great Britain. Founded in 2000, CRT has established itself as a pivotal force in cancer research and development, focusing on the commercialisation of innovative cancer therapies and technologies. With a strong presence in the UK and collaborations across Europe and North America, CRT is dedicated to advancing cancer treatment through its unique portfolio of core services, including drug development and licensing. The company is renowned for its strategic partnerships with academic institutions and pharmaceutical companies, which enhance its market position and drive significant breakthroughs in oncology. CRT's commitment to transforming scientific discoveries into viable treatments underscores its reputation as a key contributor to the fight against cancer, making it a notable entity in the global healthcare landscape.
We don't have data for Cancer Research Technology Limited, but we can show you information about their parent organization instead.
View parent company